Aclaris Therapeutics Inc (ACRS) is around the top of the Biotechnology industry according to InvestorsObserver. ACRS received an overall rating of 58, which means that it scores higher than 58 percent of all stocks. Aclaris Therapeutics Inc also achieved a score of 92 in the Biotechnology industry, putting it above 92 percent of Biotechnology stocks. Biotechnology is ranked 109 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Aclaris Therapeutics Inc Stock Today?
Aclaris Therapeutics Inc (ACRS) stock is trading at $17.93 as of 1:55 PM on Monday, Jun 14, a drop of -$0.45, or -2.45% from the previous closing price of $18.38. The stock has traded between $17.77 and $18.89 so far today. Volume today is light. So far 364,089 shares have traded compared to average volume of 741,462 shares.
Click Here to get the full Stock Score Report on Aclaris Therapeutics Inc (ACRS) Stock.
